Verastem, Inc. (VSTM)
NASDAQ: VSTM · IEX Real-Time Price · USD
2.935
-0.315 (-9.69%)
At close: Jul 2, 2024, 4:00 PM
2.930
-0.005 (-0.17%)
After-hours: Jul 2, 2024, 7:54 PM EDT
Verastem Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
73
Market Cap
74.33M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 2.60M | 543.00K | 26.45% |
Dec 31, 2021 | 2.05M | -86.46M | -97.68% |
Dec 31, 2020 | 88.52M | 71.06M | 407.08% |
Dec 31, 2019 | 17.46M | -9.26M | -34.67% |
Dec 31, 2018 | 26.72M | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 0 | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SCYNEXIS | 140.39M |
Sangamo Therapeutics | 18.76M |
DBV Technologies | 14.94M |
EUDA Health Holdings | 3.71M |
Checkpoint Therapeutics | 68.00K |
VSTM News
- 17 hours ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verastem, Inc. - VSTM - PRNewsWire
- 1 day ago - Verastem Oncology Announces Addition to Russell 3000® and Russell Microcap® Indexes - Business Wire
- 2 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Verastem, Inc. – VSTM - GlobeNewsWire
- 19 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verastem, Inc. - VSTM - GlobeNewsWire
- 22 days ago - VERASTEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Verastem, Inc. on Behalf of Verastem Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 25 days ago - Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Verastem, Inc. (VSTM) - Business Wire
- 5 weeks ago - Verastem opened 70% down on Friday: what happened? - Invezz
- 5 weeks ago - Harvest ETFs announces May 2024 Distributions - Business Wire